Abstracts - AHA Conference Repository

American Heart Association

Showing 0 Abstracts.

Acoramidis Improved Clinical Outcomes, Function, Quality of Life and NT-proBNP in Patients With Transthyretin Amyloid Cardiomyopathy Regardless of Atrial Fibrillation Status at Baseline

Sperry Brett , Tamby Jean-francois , Castano Adam , Fox Jonathan , Cheng Richard , Judge Daniel , Cappelli Francesco , Masri Ahmad , Grogan Martha , Mooney Deirdre , Akinboboye Olakunle , Drachman Brian , Nativi-nicolau Jose , Kobayashi Masatake , Chen Chris

Presentation/Board Number: MP1814

Scientific Sessions 2025

Contemporary Cardiac Amyloidosis Research

Acoramidis Lowers NT-proBNP in a Larger Proportion of ATTRibute-CM Study Participants With Transthyretin Amyloid Cardiomyopathy Compared with Placebo, Independent of Atrial Fibrillation Status

Maurer Mathew , Castano Adam , Tamby Jean-francois , Fox Jonathan , Mitter Sumeet , Hanna Mazen , Sperry Brett , Alexander Kevin , Obici Laura , Poulsen Steen , Januzzi James , Witteles Ronald , Jaber Wael , Brailovsky Yevgeniy , Vogtlaender Kai

Presentation/Board Number: MP795

Scientific Sessions 2025

Under the Sheets: Contemporary Cardiac Amyloidosis Research

Acoramidis Reduces All-Cause Mortality (ACM) and Cardiovascular-Related Hospitalization (CVH): Initial Outcomes From the ATTRibute-CM Open-Label Extension (OLE) Study

Judge Daniel , Masri Ahmad , Obici Laura , Poulsen Steen , Sarswat Nitasha , Shah Keyur , Soman Prem , Cao Xiaofan , Wang Kevin , Pecoraro Maria , Tamby Jean-francois , Gillmore Julian , Katz Leonid , Fox Jonathan , Maurer Mathew , Alexander Kevin , Ambardekar Amrut , Cappelli Francesco , Fontana Marianna , Garcia-pavia Pablo , Grogan Martha , Hanna Mazen

Presentation/Board Number: 4172052

Scientific Sessions 2024

Featured Science: Amyloid, Hypertrophic, and Danon Cardiomyopathies: Targeted Therapies and Specific Populations

Acoramidis Reduces All-Cause Mortality and Cardiovascular-Related Hospitalizations Through Month 42 in Transthyretin Amyloid Cardiomyopathy Across All Pre-specified Patient Subgroups

Stern Lily , Fine Nowell , Maurer Mathew , Grogan Martha , Ambardekar Amrut , Grodin Justin , Soman Prem , Garcia-pavia Pablo , Chen Chris , Siddhanti Suresh , Tamby Jean-francois , Fox Jonathan

Presentation/Board Number: MP977

Scientific Sessions 2025

Heart Failure and Cardiomyopathy: From Bench to Bedside

Acoramidis Reduces All-Cause Mortality and First Cardiovascular Hospitalization in Patients with Variant Transthyretin Amyloid Cardiomyopathy: Results From the ATTRibute-CM Study

Davis Margot , Soman Prem , Kittleson Michelle , Berk John , Cao Xiaofan , Tamby Jean-francois , Castano Adam , Fox Jonathan , Shah Keyur , Grogan Martha , Griffin Jan , Sarswat Nitasha , Grodin Justin , Alexander Kevin , Judge Daniel , Gillmore Julian , Cappelli Francesco , Wright Richard

Presentation/Board Number: MP790

Scientific Sessions 2025

Under the Sheets: Contemporary Cardiac Amyloidosis Research

Acoramidis Reduces the Risk of All-Cause Mortality and Cardiovascular-Related Hospitalization Compared With Placebo in Participants With Transthyretin Amyloid Cardiomyopathy and Early-Stage Heart Failure Regardless of Atrial Fibrillation History: Insights From ATTRibute-CM

Witteles Ronald , Mitter Sumeet , Gillmore Julian , Hanna Mazen , Berk John , Mitchell Joshua , Shah Keyur , Kobayashi Masatake , Xiong Kuangnan , Castano Adam , Tamby Jean-francois , Fox Jonathan

Presentation/Board Number: MP1020

Scientific Sessions 2025

Arrhythmic Risks in Infiltrative Cardiomyopathy: Pathophysiology and Management